Skip to main content
Top
Published in: Pediatric Rheumatology 1/2014

Open Access 01-12-2014 | Short Report

Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis)

Authors: Marek Bohm, Maria Isabel Gonzalez Fernandez, Seza Ozen, Angela Pistorio, Pavla Dolezalova, Paul Brogan, Giancarlo Barbano, Claudia Sengler, Marisa Klein-Gitelman, Pierre Quartier, Anders Fasth, Troels Herlin, Maria Teresa R A Terreri, Susan Nielsen, Marion A J van Rossum, Tadej Avcin, Esteban Rodolfo Castell, Ivan Foeldvari, Dirk Foell, Anuela Kondi, Isabelle Koné-Paut, Rolf-Michael Kuester, Hartmut Michels, Nico Wulffraat, Halima Ben Amer, Clara Malattia, Alberto Martini, Nicolino Ruperto, the Paediatric Rheumatology International Trials Organisation (PRINTO)

Published in: Pediatric Rheumatology | Issue 1/2014

Login to get access

Abstract

Background

Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis (WG), belongs to the group of ANCA-associated necrotizing vasculitides. This study describes the clinical picture of the disease in a large cohort of GPA paediatric patients.
Children with age at diagnosis ≤ 18 years, fulfilling the EULAR/PRINTO/PRES GPA/WG classification criteria were extracted from the PRINTO vasculitis database. The clinical signs/symptoms and laboratory features were analysed before or at the time of diagnosis and at least 3 months thereafter and compared with other paediatric and adult case series (>50 patients) derived from the literature.

Findings

The 56 children with GPA/WG were predominantly females (68%) and Caucasians (82%) with a median age at disease onset of 11.7 years, and a median delay in diagnosis of 4.2 months. The most frequent organ systems involved before/at the time of diagnosis were ears, nose, throat (91%), constitutional (malaise, fever, weight loss) (89%), respiratory (79%), mucosa and skin (64%), musculoskeletal (59%), and eye (35%), 67% were ANCA-PR3 positive, while haematuria/proteinuria was present in > 50% of the children. In adult series, the frequency of female involvement ranged from 29% to 50% with lower frequencies of constitutional (fever, weight loss), ears, nose, throat (oral/nasal ulceration, otitis/aural discharge), respiratory (tracheal/endobronchial stenosis/obstruction), laboratory involvement and higher frequency of conductive hearing loss than in this paediatric series.

Conclusions

Paediatric patients compared to adults with GPA/WG have similar pattern of clinical manifestations but different frequencies of organ involvement.
Literature
1.
go back to reference Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R: Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011, 70: 704-10.1136/ard.2011.150714.CrossRefPubMed Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R: Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011, 70: 704-10.1136/ard.2011.150714.CrossRefPubMed
2.
go back to reference Mahr AD, Neogi T, Merkel PA: Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006, 24: S82-S91.PubMed Mahr AD, Neogi T, Merkel PA: Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006, 24: S82-S91.PubMed
3.
go back to reference Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Granulomatous vasculitis, giant cell arteritis and sarcoidosis. In: Textbook of pediatric rheumatology. Harcourt Health Science Company, editor: Sixth edition:315–343. 2010, Philadelphia, USA: W.B.Saunders Company Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Granulomatous vasculitis, giant cell arteritis and sarcoidosis. In: Textbook of pediatric rheumatology. Harcourt Health Science Company, editor: Sixth edition:315–343. 2010, Philadelphia, USA: W.B.Saunders Company
4.
go back to reference Hellmich B, Lamprecht P, Gross WL: Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol. 2006, 18: 25-32. 10.1097/01.bor.0000200369.24793.f5.CrossRefPubMed Hellmich B, Lamprecht P, Gross WL: Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol. 2006, 18: 25-32. 10.1097/01.bor.0000200369.24793.f5.CrossRefPubMed
5.
go back to reference Falk RJ, Jennette JC: Rituximab in ANCA-associated disease. N Engl J Med. 2010, 363: 285-286. 10.1056/NEJMe1004992.CrossRefPubMed Falk RJ, Jennette JC: Rituximab in ANCA-associated disease. N Engl J Med. 2010, 363: 285-286. 10.1056/NEJMe1004992.CrossRefPubMed
6.
go back to reference Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, DeWitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D: Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009, 60: 3413-3424. 10.1002/art.24876.CrossRefPubMed Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, DeWitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D: Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009, 60: 3413-3424. 10.1002/art.24876.CrossRefPubMed
7.
go back to reference Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363: 221-232. 10.1056/NEJMoa0909905.PubMedCentralCrossRefPubMed Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363: 221-232. 10.1056/NEJMoa0909905.PubMedCentralCrossRefPubMed
8.
go back to reference Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van PP, Walsh D, Walsh M, Westman K, Jayne DR: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363: 211-220. 10.1056/NEJMoa0909169.CrossRefPubMed Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van PP, Walsh D, Walsh M, Westman K, Jayne DR: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363: 211-220. 10.1056/NEJMoa0909169.CrossRefPubMed
9.
go back to reference Bosch X, Guilabert A, Espinosa G, Mirapeix E: Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007, 298: 655-669. 10.1001/jama.298.6.655.CrossRefPubMed Bosch X, Guilabert A, Espinosa G, Mirapeix E: Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007, 298: 655-669. 10.1001/jama.298.6.655.CrossRefPubMed
10.
go back to reference Koldingsnes W, Nossent H: Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 2000, 43: 2481-2487. 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6.CrossRefPubMed Koldingsnes W, Nossent H: Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum. 2000, 43: 2481-2487. 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6.CrossRefPubMed
11.
go back to reference Mahr AD, Neogi T, LaValley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA: Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum. 2008, 59: 884-891. 10.1002/art.23707.PubMedCentralCrossRefPubMed Mahr AD, Neogi T, LaValley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA: Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum. 2008, 59: 884-891. 10.1002/art.23707.PubMedCentralCrossRefPubMed
12.
go back to reference Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G: Clinical characteristics and long-term outcomes of 35 patients with Wegener's granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas ). 2010, 46: 256-260. Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G: Clinical characteristics and long-term outcomes of 35 patients with Wegener's granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas ). 2010, 46: 256-260.
13.
go back to reference Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS: Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993, 122: 26-31. 10.1016/S0022-3476(05)83482-1.CrossRefPubMed Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS: Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993, 122: 26-31. 10.1016/S0022-3476(05)83482-1.CrossRefPubMed
14.
go back to reference Belostotsky VM, Shah V, Dillon MJ: Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002, 17: 754-761. 10.1007/s00467-002-0914-2.CrossRefPubMed Belostotsky VM, Shah V, Dillon MJ: Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002, 17: 754-761. 10.1007/s00467-002-0914-2.CrossRefPubMed
15.
go back to reference Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006, 65: 936-941.PubMedCentralCrossRefPubMed Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006, 65: 936-941.PubMedCentralCrossRefPubMed
16.
go back to reference Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhaes CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Paut IK, Zulian F, Barone P, Bircan Z, Maldonado MR, Russo R: EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis. 2010, 69: 790-797. 10.1136/ard.2009.116624.CrossRefPubMed Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhaes CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Paut IK, Zulian F, Barone P, Bircan Z, Maldonado MR, Russo R: EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis. 2010, 69: 790-797. 10.1136/ard.2009.116624.CrossRefPubMed
17.
go back to reference Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M: EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010, 69: 798-806. 10.1136/ard.2009.116657.CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M: EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010, 69: 798-806. 10.1136/ard.2009.116657.CrossRefPubMed
18.
go back to reference Mina R, Brunner HI: Pediatric lupus–are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am. 2010, 36: 53-80. 10.1016/j.rdc.2009.12.012.PubMedCentralCrossRefPubMed Mina R, Brunner HI: Pediatric lupus–are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am. 2010, 36: 53-80. 10.1016/j.rdc.2009.12.012.PubMedCentralCrossRefPubMed
19.
go back to reference Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A, Moini B, Cabalar I, Lovell DJ, Wesley R, Plotz PH, Miller FW, Hicks JE, Rider LG: Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford). 2009, 48: 134-139.CrossRef Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A, Moini B, Cabalar I, Lovell DJ, Wesley R, Plotz PH, Miller FW, Hicks JE, Rider LG: Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford). 2009, 48: 134-139.CrossRef
20.
go back to reference Mahr A, Girard T, Agher R, Guillevin L: Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology (Oxford). 2001, 40: 492-498. 10.1093/rheumatology/40.5.492.CrossRef Mahr A, Girard T, Agher R, Guillevin L: Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology (Oxford). 2001, 40: 492-498. 10.1093/rheumatology/40.5.492.CrossRef
Metadata
Title
Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis)
Authors
Marek Bohm
Maria Isabel Gonzalez Fernandez
Seza Ozen
Angela Pistorio
Pavla Dolezalova
Paul Brogan
Giancarlo Barbano
Claudia Sengler
Marisa Klein-Gitelman
Pierre Quartier
Anders Fasth
Troels Herlin
Maria Teresa R A Terreri
Susan Nielsen
Marion A J van Rossum
Tadej Avcin
Esteban Rodolfo Castell
Ivan Foeldvari
Dirk Foell
Anuela Kondi
Isabelle Koné-Paut
Rolf-Michael Kuester
Hartmut Michels
Nico Wulffraat
Halima Ben Amer
Clara Malattia
Alberto Martini
Nicolino Ruperto
the Paediatric Rheumatology International Trials Organisation (PRINTO)
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2014
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-12-18

Other articles of this Issue 1/2014

Pediatric Rheumatology 1/2014 Go to the issue